tiprankstipranks
Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX
US Market

Aldeyra Therapeutics (ALDX) Income Statement

Compare
1,569 Followers

Aldeyra Therapeutics Income Statement

Last quarter (Q3 2024), Aldeyra Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Aldeyra Therapeutics's net income was $-15.11M. See Aldeyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -262.78K$ -258.71K$ -264.18K$ -56.22K$ -96.31K
Operating Expenses
$ 42.79M$ 62.68M$ 56.22M$ 34.67M$ 56.51M
Depreciation and Amortization
$ 262.78K$ 258.71K$ 264.18K$ 56.22K$ 96.31K
EBITDA
$ -35.21M$ -60.07M$ -55.77M$ -36.07M$ -61.44M
Operating Income
$ -42.79M$ -62.68M$ -56.22M$ -36.42M$ -63.07M
Other Income/Expenses
$ 5.25M$ 655.35K$ -1.56M$ -3.37M$ -5.63M
Pretax Income
$ -37.54M$ -62.02M$ -57.78M$ -38.03M$ -62.14M
Net Income
$ -37.54M$ -61.37M$ -59.25M$ -37.55M$ -60.83M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.64$ -1.05$ -1.10$ -1.11$ -2.24
Diluted EPS
$ -0.64$ -1.05$ -1.10$ -1.11$ -2.24
Weighted Average Shares Outstanding
58.94M 58.41M 54.04M 33.97M 27.11M
Weighted Average Shares Outstanding (Diluted)
58.94M 58.41M 54.04M 33.97M 27.11M
Currency in USD

Aldeyra Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis